Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Price to free cash flow ratio
Latest
-66.98
↓ 565% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
-10.08
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -66.98 | -863.0% |
| 2024 | -6.96 | -368.2% |
| 2023 | -1.49 | -214.1% |
| 2022 | -0.47 | +91.8% |
| 2021 | -5.75 | -9.6% |
| 2020 | -5.25 | -44.4% |
| 2019 | -3.63 | +24.0% |
| 2018 | -4.78 | -47.4% |
| 2017 | -3.24 | -45.1% |
| 2016 | -2.24 | - |